261 related articles for article (PubMed ID: 18070148)
1. Translational mini-review series on complement factor H: therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritis.
Noris M; Remuzzi G
Clin Exp Immunol; 2008 Feb; 151(2):199-209. PubMed ID: 18070148
[TBL] [Abstract][Full Text] [Related]
2. Membrano-proliferative glomerulonephritis, atypical hemolytic uremic syndrome, and a new complement factor H mutation: report of a case.
Gnappi E; Allinovi M; Vaglio A; Bresin E; Sorosina A; Pilato FP; Allegri L; Manenti L
Pediatr Nephrol; 2012 Oct; 27(10):1995-9. PubMed ID: 22669321
[TBL] [Abstract][Full Text] [Related]
3. Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals.
Pickering MC; Cook HT
Clin Exp Immunol; 2008 Feb; 151(2):210-30. PubMed ID: 18190458
[TBL] [Abstract][Full Text] [Related]
4. Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H.
de Córdoba SR; de Jorge EG
Clin Exp Immunol; 2008 Jan; 151(1):1-13. PubMed ID: 18081690
[TBL] [Abstract][Full Text] [Related]
5. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.
Servais A; Frémeaux-Bacchi V; Lequintrec M; Salomon R; Blouin J; Knebelmann B; Grünfeld JP; Lesavre P; Noël LH; Fakhouri F
J Med Genet; 2007 Mar; 44(3):193-9. PubMed ID: 17018561
[TBL] [Abstract][Full Text] [Related]
6. Complement factor H and haemolytic uraemic syndrome.
Mathieson P
Lancet; 2002 Mar; 359(9308):801-2. PubMed ID: 11888630
[No Abstract] [Full Text] [Related]
7. Complement in glomerular injury.
Berger SP; Daha MR
Semin Immunopathol; 2007 Nov; 29(4):375-84. PubMed ID: 17901956
[TBL] [Abstract][Full Text] [Related]
8. Factor H family proteins and human diseases.
Józsi M; Zipfel PF
Trends Immunol; 2008 Aug; 29(8):380-7. PubMed ID: 18602340
[TBL] [Abstract][Full Text] [Related]
9. Factor H genotype-phenotype correlations: lessons from aHUS, MPGN II, and AMD.
Goodship TH
Kidney Int; 2006 Jul; 70(1):12-3. PubMed ID: 16810287
[TBL] [Abstract][Full Text] [Related]
10. The spectrum of phenotypes caused by variants in the CFH gene.
Boon CJ; van de Kar NC; Klevering BJ; Keunen JE; Cremers FP; Klaver CC; Hoyng CB; Daha MR; den Hollander AI
Mol Immunol; 2009 May; 46(8-9):1573-94. PubMed ID: 19297022
[TBL] [Abstract][Full Text] [Related]
11. Complement factor H variants I890 and L1007 while commonly associated with atypical hemolytic uremic syndrome are polymorphisms with no functional significance.
Tortajada A; Pinto S; Martínez-Ara J; López-Trascasa M; Sánchez-Corral P; de Córdoba SR
Kidney Int; 2012 Jan; 81(1):56-63. PubMed ID: 21881555
[TBL] [Abstract][Full Text] [Related]
12. Heterozygous and homozygous factor h deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases.
Dragon-Durey MA; Frémeaux-Bacchi V; Loirat C; Blouin J; Niaudet P; Deschenes G; Coppo P; Herman Fridman W; Weiss L
J Am Soc Nephrol; 2004 Mar; 15(3):787-95. PubMed ID: 14978182
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains.
Pickering MC; de Jorge EG; Martinez-Barricarte R; Recalde S; Garcia-Layana A; Rose KL; Moss J; Walport MJ; Cook HT; de Córdoba SR; Botto M
J Exp Med; 2007 Jun; 204(6):1249-56. PubMed ID: 17517971
[TBL] [Abstract][Full Text] [Related]
14. Factor H and the pathogenesis of renal diseases.
Ault BH
Pediatr Nephrol; 2000 Sep; 14(10-11):1045-53. PubMed ID: 10975323
[TBL] [Abstract][Full Text] [Related]
15. Familial mesangio-capillary glomerulonephritis with initial presentation as haemolytic uraemic syndrome.
Cooper M; McGraw ME; Unsworth DJ; Mathieson P
Nephrol Dial Transplant; 2004 Jan; 19(1):230-3. PubMed ID: 14671063
[No Abstract] [Full Text] [Related]
16. Atypical haemolytic-uraemic syndrome due to heterozygous mutations of CFH/CFHR1-3 and complement factor H 479.
Chaudhary P; Hepgur M; Sarkissian S; Smith RJ; Weitz IC
Blood Transfus; 2014 Jan; 12(1):111-3. PubMed ID: 24333077
[No Abstract] [Full Text] [Related]
17. Retinal disease in the C3 glomerulopathies and the risk of impaired vision.
Savige J; Amos L; Ierino F; Mack HG; Symons RC; Hughes P; Nicholls K; Colville D
Ophthalmic Genet; 2016 Dec; 37(4):369-376. PubMed ID: 26915021
[TBL] [Abstract][Full Text] [Related]
18. Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome.
Abarrategui-Garrido C; Martínez-Barricarte R; López-Trascasa M; de Córdoba SR; Sánchez-Corral P
Blood; 2009 Nov; 114(19):4261-71. PubMed ID: 19745068
[TBL] [Abstract][Full Text] [Related]
19. Atypical haemolytic uraemic syndrome.
Kavanagh D; Goodship TH; Richards A
Br Med Bull; 2006; 77-78():5-22. PubMed ID: 16968692
[TBL] [Abstract][Full Text] [Related]
20. Do complement factor H 402Y and C7 M allotypes predispose to (typical) haemolytic uraemic syndrome?
Poolpol K; Gadner B; Neururer S; Mellmann A; Karch H; Orth D; Würzner R
Int J Immunogenet; 2011 Oct; 38(5):383-7. PubMed ID: 21649859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
